G

Gentian Diagnostics ASA
OSE:GENT

Watchlist Manager
Gentian Diagnostics ASA
OSE:GENT
Watchlist
Price: 41 NOK 6.22% Market Closed
Market Cap: 632.3m NOK
Have any thoughts about
Gentian Diagnostics ASA?
Write Note

Intrinsic Value

The intrinsic value of one GENT stock under the Base Case scenario is 34.32 NOK. Compared to the current market price of 41 NOK, Gentian Diagnostics ASA is Overvalued by 16%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GENT Intrinsic Value
34.32 NOK
Overvaluation 16%
Intrinsic Value
Price
G
Worst Case
Base Case
Best Case

Valuation History
Gentian Diagnostics ASA

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
GENT
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for GENT cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about GENT?
Bearish
Neutral
Bullish

Fundamental Analysis

41 NOK
+6.22%
+6.22%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Gentian Diagnostics ASA
NO
Health Care
Market Cap
632.3m NOK
IPO
Dec 14, 2016
Employees
52
Norway
Market Cap
632.3m NOK
Industry
Health Care
IPO
Dec 14, 2016
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Gentian Diagnostics ASA

Provide an overview of the primary business activities
of Gentian Diagnostics ASA.

What unique competitive advantages
does Gentian Diagnostics ASA hold over its rivals?

What risks and challenges
does Gentian Diagnostics ASA face in the near future?

Summarize the latest earnings call
of Gentian Diagnostics ASA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Gentian Diagnostics ASA.

Provide P/S
for Gentian Diagnostics ASA.

Provide P/E
for Gentian Diagnostics ASA.

Provide P/OCF
for Gentian Diagnostics ASA.

Provide P/FCFE
for Gentian Diagnostics ASA.

Provide P/B
for Gentian Diagnostics ASA.

Provide EV/S
for Gentian Diagnostics ASA.

Provide EV/GP
for Gentian Diagnostics ASA.

Provide EV/EBITDA
for Gentian Diagnostics ASA.

Provide EV/EBIT
for Gentian Diagnostics ASA.

Provide EV/OCF
for Gentian Diagnostics ASA.

Provide EV/FCFF
for Gentian Diagnostics ASA.

Provide EV/IC
for Gentian Diagnostics ASA.

Show me price targets
for Gentian Diagnostics ASA made by professional analysts.

What are the Revenue projections
for Gentian Diagnostics ASA?

How accurate were the past Revenue estimates
for Gentian Diagnostics ASA?

What are the Net Income projections
for Gentian Diagnostics ASA?

How accurate were the past Net Income estimates
for Gentian Diagnostics ASA?

What are the EPS projections
for Gentian Diagnostics ASA?

How accurate were the past EPS estimates
for Gentian Diagnostics ASA?

What are the EBIT projections
for Gentian Diagnostics ASA?

How accurate were the past EBIT estimates
for Gentian Diagnostics ASA?

Compare the revenue forecasts
for Gentian Diagnostics ASA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Gentian Diagnostics ASA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Gentian Diagnostics ASA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Gentian Diagnostics ASA compared to its peers.

Compare the P/E ratios
of Gentian Diagnostics ASA against its peers.

Discuss the investment returns and shareholder value creation
comparing Gentian Diagnostics ASA with its peers.

Analyze the financial leverage
of Gentian Diagnostics ASA compared to its main competitors.

Show all profitability ratios
for Gentian Diagnostics ASA.

Provide ROE
for Gentian Diagnostics ASA.

Provide ROA
for Gentian Diagnostics ASA.

Provide ROIC
for Gentian Diagnostics ASA.

Provide ROCE
for Gentian Diagnostics ASA.

Provide Gross Margin
for Gentian Diagnostics ASA.

Provide Operating Margin
for Gentian Diagnostics ASA.

Provide Net Margin
for Gentian Diagnostics ASA.

Provide FCF Margin
for Gentian Diagnostics ASA.

Show all solvency ratios
for Gentian Diagnostics ASA.

Provide D/E Ratio
for Gentian Diagnostics ASA.

Provide D/A Ratio
for Gentian Diagnostics ASA.

Provide Interest Coverage Ratio
for Gentian Diagnostics ASA.

Provide Altman Z-Score Ratio
for Gentian Diagnostics ASA.

Provide Quick Ratio
for Gentian Diagnostics ASA.

Provide Current Ratio
for Gentian Diagnostics ASA.

Provide Cash Ratio
for Gentian Diagnostics ASA.

What is the historical Revenue growth
over the last 5 years for Gentian Diagnostics ASA?

What is the historical Net Income growth
over the last 5 years for Gentian Diagnostics ASA?

What is the current Free Cash Flow
of Gentian Diagnostics ASA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Gentian Diagnostics ASA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Gentian Diagnostics ASA

Current Assets 147.5m
Cash & Short-Term Investments 93.8m
Receivables 11.1m
Other Current Assets 42.6m
Non-Current Assets 41.6m
Long-Term Investments 104k
PP&E 15.4m
Intangibles 26m
Other Non-Current Assets -1k
Current Liabilities 21m
Other Current Liabilities 21m
Non-Current Liabilities 6.7m
Long-Term Debt 6.6m
Other Non-Current Liabilities 75k
Efficiency

Earnings Waterfall
Gentian Diagnostics ASA

Revenue
146.9m NOK
Cost of Revenue
-71m NOK
Gross Profit
75.9m NOK
Operating Expenses
-76m NOK
Operating Income
-41k NOK
Other Expenses
2.3m NOK
Net Income
2.2m NOK

Free Cash Flow Analysis
Gentian Diagnostics ASA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

GENT Profitability Score
Profitability Due Diligence

Gentian Diagnostics ASA's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROIC is Increasing
Exceptional 3-Years Revenue Growth
ROE is Increasing
36/100
Profitability
Score

Gentian Diagnostics ASA's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

GENT Solvency Score
Solvency Due Diligence

Gentian Diagnostics ASA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Gentian Diagnostics ASA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GENT Price Targets Summary
Gentian Diagnostics ASA

Wall Street analysts forecast GENT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GENT is 68.34 NOK with a low forecast of 67.67 NOK and a high forecast of 70.35 NOK.

Lowest
Price Target
67.67 NOK
65% Upside
Average
Price Target
68.34 NOK
67% Upside
Highest
Price Target
70.35 NOK
72% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for GENT?

Click here to dive deeper.

Dividends

Gentian Diagnostics ASA
does not pay dividends
Shareholder Yield

Current shareholder yield for GENT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one GENT stock?

The intrinsic value of one GENT stock under the Base Case scenario is 34.32 NOK.

Is GENT stock undervalued or overvalued?

Compared to the current market price of 41 NOK, Gentian Diagnostics ASA is Overvalued by 16%.

Back to Top